DD202011A5 - Verfahren zur herstellung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5 methylsulfamoylbenzamid - Google Patents

Verfahren zur herstellung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5 methylsulfamoylbenzamid Download PDF

Info

Publication number
DD202011A5
DD202011A5 DD81232783A DD23278381A DD202011A5 DD 202011 A5 DD202011 A5 DD 202011A5 DD 81232783 A DD81232783 A DD 81232783A DD 23278381 A DD23278381 A DD 23278381A DD 202011 A5 DD202011 A5 DD 202011A5
Authority
DD
German Democratic Republic
Prior art keywords
methoxy
amino
benzamide
allyl
pyrrolidinylmethyl
Prior art date
Application number
DD81232783A
Other languages
German (de)
English (en)
Inventor
Jacques Perrot
Michel Thominet
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DD202011A5 publication Critical patent/DD202011A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
DD81232783A 1980-08-28 1981-08-25 Verfahren zur herstellung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5 methylsulfamoylbenzamid DD202011A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament

Publications (1)

Publication Number Publication Date
DD202011A5 true DD202011A5 (de) 1983-08-24

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81232783A DD202011A5 (de) 1980-08-28 1981-08-25 Verfahren zur herstellung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5 methylsulfamoylbenzamid

Country Status (41)

Country Link
US (2) US4405636A (es)
EP (1) EP0047207B1 (es)
JP (1) JPS5775969A (es)
KR (1) KR840002063B1 (es)
AR (1) AR226737A1 (es)
AT (1) ATE11911T1 (es)
AU (1) AU549396B2 (es)
BE (1) BE890085A (es)
BG (1) BG36931A3 (es)
CA (1) CA1168250A (es)
CH (1) CH648299A5 (es)
CS (1) CS223895B2 (es)
DD (1) DD202011A5 (es)
DE (2) DE3169052D1 (es)
DK (1) DK157845C (es)
EG (1) EG15376A (es)
ES (1) ES503805A0 (es)
FI (1) FI73207C (es)
FR (1) FR2489327B1 (es)
GB (1) GB2083033B (es)
GR (1) GR74560B (es)
HK (1) HK55989A (es)
HU (1) HU183555B (es)
IE (1) IE51357B1 (es)
IL (1) IL63217A (es)
IN (1) IN155495B (es)
IS (1) IS1213B6 (es)
IT (1) IT1171490B (es)
JO (1) JO1120B1 (es)
LU (1) LU83583A1 (es)
MA (1) MA19218A1 (es)
MX (1) MX6707E (es)
NO (1) NO155097C (es)
OA (1) OA06877A (es)
PH (1) PH19211A (es)
PL (1) PL135397B1 (es)
PT (1) PT73509B (es)
SU (1) SU1148559A3 (es)
YU (1) YU42581B (es)
ZA (1) ZA814575B (es)
ZW (1) ZW17581A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (es) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (es) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (es) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
AU7464281A (en) 1982-03-04
DE3169052D1 (en) 1985-03-28
GB2083033A (en) 1982-03-17
PH19211A (en) 1986-02-04
YU201081A (en) 1983-10-31
NO155097B (no) 1986-11-03
KR840002063B1 (ko) 1984-11-09
IS2654A7 (is) 1981-09-11
ZW17581A1 (en) 1981-10-21
LU83583A1 (fr) 1981-12-01
AR226737A1 (es) 1982-08-13
HU183555B (en) 1984-05-28
IL63217A (en) 1985-03-31
SU1148559A3 (ru) 1985-03-30
BE890085A (fr) 1982-02-26
PL135397B1 (en) 1985-10-31
JPH0233027B2 (es) 1990-07-25
FR2489327A1 (fr) 1982-03-05
MA19218A1 (fr) 1982-04-01
GB2083033B (en) 1984-02-01
FI73207B (fi) 1987-05-29
JPS5775969A (en) 1982-05-12
GR74560B (es) 1984-06-29
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
YU42581B (en) 1988-10-31
IN155495B (es) 1985-02-09
IL63217A0 (en) 1981-10-30
FI73207C (fi) 1987-09-10
HK55989A (en) 1989-07-21
CA1168250A (fr) 1984-05-29
DK383081A (da) 1982-03-01
PL232686A1 (es) 1982-03-01
NO155097C (no) 1987-02-11
PT73509B (fr) 1982-10-28
BG36931A3 (en) 1985-02-15
EP0047207A1 (fr) 1982-03-10
IE51357B1 (en) 1986-12-10
US4405636A (en) 1983-09-20
NO812937L (no) 1982-03-01
IS1213B6 (is) 1986-04-02
ZA814575B (en) 1982-07-28
DE3133768A1 (de) 1982-06-16
DK157845C (da) 1990-07-23
CH648299A5 (fr) 1985-03-15
IT8149179A0 (it) 1981-08-26
IT1171490B (it) 1987-06-10
FR2489327B1 (fr) 1984-05-18
ATE11911T1 (de) 1985-03-15
KR830006201A (ko) 1983-09-20
FI812506L (fi) 1982-03-01
PT73509A (fr) 1981-09-01
DK157845B (da) 1990-02-26
IE811449L (en) 1982-02-28
ES8301466A1 (es) 1982-12-01
MX6707E (es) 1985-10-23
ES503805A0 (es) 1982-12-01
US4550179A (en) 1985-10-29
AU549396B2 (en) 1986-01-23
JO1120B1 (en) 1982-07-10
CS223895B2 (en) 1983-11-25
OA06877A (fr) 1983-04-30

Similar Documents

Publication Publication Date Title
DE2655883C2 (es)
DE2901181A1 (de) 2-methoxy-4-amino-5-alkylsulfonylbenzamide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2508045C2 (de) N-(1'-Benzylpyrrolidinyl-2'-methyl)-2-methoxybenzamid-Derivate, Verfahren zur ihrer Herstellung und diese enthaltende Arzneimittel
DE1493536B1 (de) Neue gamma-Amino-beta-phenyl-buttersaeuren
DD202011A5 (de) Verfahren zur herstellung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5 methylsulfamoylbenzamid
DE2362754C2 (de) Cyclopropylalkylaminoreste enthaltende Oxazolinverbindungen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DD143254A5 (de) Verfahren zur herstellung von tetrahydroisochinolin-derivaten
DE1245357B (de) Verfahren zur Herstellung von basischen AEthern von substituierten Hydroxybenzoesaeureamiden
DE1816993A1 (de) Verfahren zur Herstellung von 1-Aoyl- oder 1-Heteroaroyl- oder 1-Benzheteroaroyl-2-methyl-5-alkoxy-(oder 5-aralkoxy)-indolyl-3-essigsaeuren
DE953256C (de) Verfahren zur Herstellung von therapeutisch wirksamen bis-[ª‰-(o-Oxyphenyl)-isopropyl]-aminen
DE1670143C3 (es)
CH643831A5 (de) Cinnamyl-moranolin-derivate.
DE1966215A1 (de) Verfahren zur Herstellung von heterocyclischen Benzamiden
AT317196B (de) Verfahren zur Herstellung neuer 1-Benzoyloxy-2-niedrig-alkylaminobenzocycloalkanderivate
AT333266B (de) Verfahren zur herstellung neuer 1-benzoyloxy-2-dimethylaminobenzocycloalkanderivate
AT213864B (de) Verfahren zur Herstellung von neuen analgetisch wirksamen α-Amino-β-oxybuttersäureamiden
DE1111209B (de) Verfahren zur Herstellung eines neuen Phenylalkylolamins mit hustenreizstillenden Eigenschaften
DE2132562C (de) (+) 3r N Monomethylamino 4c phenyl 4t athoxycarbonyl cyclohexen (1), dessen D bzw L O,O Dibenzoyltartrat, Hydro Chlorid bzw andere Salze physiologisch unbedenklicher Sauren und Verfahren zu deren Herstellung
DE2628911A1 (de) Neue schwefelhaltige n-benzylaminosaeuren und verfahren zu ihrer herstellung
AT228199B (de) Verfahren zur Herstellung eines neuen Imidazolinderivates und seiner Salze
AT300763B (de) Verfahren zur Herstellung von neuen 5-(1'-Hydroxy-2'-arylalkyl-oder -aryloxyalkylaminoäthyl)-salicylamiden und deren Säureadditionssalzen
AT282593B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
DE1518311C (de) N (2 Diathylaminoathyl) 2 methoxy 3,4 bzw 4,5 methylendioxybenzamid und deren pharmakologisch nicht giftige Saureadditions salze
DE1768908C3 (de) Verfahren zur Herstellung von aromatischen N-substituierten Amidinen, neue aromatische N-substltuierte Amidine und ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
DE2029991B2 (de) 2-hydroxy-5-aminobenzamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten